Description
What is this product?
Entyvio is an integrin receptor antagonist used to treat adult patients with ulcerative colitis and Crohn’s disease. This product is manufactured by Takeda Pharmaceuticals, a Japanese pharmaceutical company. Entyvio is used for injection and supplied in a single-dose vial for injection.
What is it made of?
Entyvio 300mg contains vedolizumab, a humanized immunoglobulin G1 monoclonal antibody sourced from Chinese hamster ovary cells.
